Stock Track | Progyny Plunges 8.76% Post-Market on Disappointing Growth Outlook and Client Loss

Stock Track02-27

Progyny's stock experienced a significant post-market plunge of 8.76% on Thursday, following the release of its latest financial results and forward guidance.

The sharp decline was primarily driven by investor concerns over the company's growth trajectory. While Progyny reported better-than-expected fourth-quarter 2025 revenue, its outlook for fiscal year 2026 projects a slowdown in revenue growth to a range of 5.1% to 9%, compared to 10% growth in 2025. Additionally, first-quarter 2026 revenue growth guidance of just 2.5% fell well below analyst expectations.

Further contributing to the negative sentiment was the confirmed loss of a large client that did not renew for 2025, resulting in no revenue contribution in the fourth quarter. The company's pharmacy benefit services segment also reported a 1.1% revenue decline during the quarter, adding to concerns about future growth prospects across its business lines.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155619345?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 09:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155619345","market":"nz","top_or_hot":-1,"title":"Stock Track | Progyny Plunges 8.76% Post-Market on Disappointing Growth Outlook and Client Loss","media":"Stock Track","content":"<p>Progyny's stock experienced a significant post-market plunge of 8.76% on Thursday, following the release of its latest financial results and forward guidance.</p><p>The sharp decline was primarily driven by investor concerns over the company's growth trajectory. While Progyny reported better-than-expected fourth-quarter 2025 revenue, its outlook for fiscal year 2026 projects a slowdown in revenue growth to a range of 5.1% to 9%, compared to 10% growth in 2025. Additionally, first-quarter 2026 revenue growth guidance of just 2.5% fell well below analyst expectations.</p><p>Further contributing to the negative sentiment was the confirmed loss of a large client that did not renew for 2025, resulting in no revenue contribution in the fourth quarter. The company's pharmacy benefit services segment also reported a 1.1% revenue decline during the quarter, adding to concerns about future growth prospects across its business lines.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Progyny Plunges 8.76% Post-Market on Disappointing Growth Outlook and Client Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Progyny Plunges 8.76% Post-Market on Disappointing Growth Outlook and Client Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-27 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Progyny's stock experienced a significant post-market plunge of 8.76% on Thursday, following the release of its latest financial results and forward guidance.</p><p>The sharp decline was primarily driven by investor concerns over the company's growth trajectory. While Progyny reported better-than-expected fourth-quarter 2025 revenue, its outlook for fiscal year 2026 projects a slowdown in revenue growth to a range of 5.1% to 9%, compared to 10% growth in 2025. Additionally, first-quarter 2026 revenue growth guidance of just 2.5% fell well below analyst expectations.</p><p>Further contributing to the negative sentiment was the confirmed loss of a large client that did not renew for 2025, resulting in no revenue contribution in the fourth quarter. The company's pharmacy benefit services segment also reported a 1.1% revenue decline during the quarter, adding to concerns about future growth prospects across its business lines.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PGNY","symbol_name":"Progyny","start_time":0,"source_url":"","article_id":"1155619345","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155619345","pubTimestamp":1772155138,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Progyny's stock experienced a significant post-market plunge of 8.76% on Thursday, following the release of its latest financial results and forward guidance.The sharp decline was primarily driven by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PGNY":"Progyny"},"translate_title":"个股追踪|Progyny盘后暴跌8.76%，因增长前景令人失望和客户流失","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGNY":1},"content_text":"Progyny's stock experienced a significant post-market plunge of 8.76% on Thursday, following the release of its latest financial results and forward guidance.The sharp decline was primarily driven by investor concerns over the company's growth trajectory. While Progyny reported better-than-expected fourth-quarter 2025 revenue, its outlook for fiscal year 2026 projects a slowdown in revenue growth to a range of 5.1% to 9%, compared to 10% growth in 2025. Additionally, first-quarter 2026 revenue growth guidance of just 2.5% fell well below analyst expectations.Further contributing to the negative sentiment was the confirmed loss of a large client that did not renew for 2025, resulting in no revenue contribution in the fourth quarter. The company's pharmacy benefit services segment also reported a 1.1% revenue decline during the quarter, adding to concerns about future growth prospects across its business lines.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155619345","isCrawlerRequest":true}